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Functional correction of renal defects in a mouse model for ARPKD
through expression of the cloned wild-type Tg737 cDNA. Autosomal
recessive polycystic kidney disease (ARPKD) is characterized by the
formation of large collecting tubule and ductular cysts that often result in
renal insufficiency within the first decade of life. Understanding the
process leading to cyst formation will require the identification and
characterization of genes involved in the etiology of this disease. In this
regard, we previously described the generation of a mouse model
(TgN737Rpw) for ARPKD and the cloning of a candidate gene. Here we
show direct involvement of the Tg737 gene in collecting duct cyst
formation by expressing the wild-type Tg737 eDNA as a transgene in
TgN737Rpw mutants. In contrast to TgN737Rpw mutants, the 'rescued"
animals survive longer, have normal renal function and normal localiza-
tion of the EGFr to the basolateral surfaces of collecting duct epithelium.
The development of polycystic kidneys is common to several
different heritable genetic disorders in humans and is most often
observed in individuals with autosomal dominant (ADPKD) or
autosomal recessive (ARPKD) polycystic kidney disease [1—9].
Collectively, PKD is one of the most common genetic disorders in
humans, with a combined incidence of about 1:500 to 1:1,000
individuals. It has been estimated that PKD accounts for 10% of
all cases requiring long-term dialysis or renal transplantation and
is a major cause of chronic renal failure in humans [10, 111.
Specifically, patients with ARPKD develop renal lesions that
are initially detected as dilations of the proximal tubules. This is
followed rapidly by the development of large cystic lesions in the
collecting tubules and collecting ducts. Expansion of these cystic
structures results in damage to the surrounding parenchyma and
leads to end-stage renal disease and neonatal death.
Several animal models have been generated to study the renal
lesion in PKD; however, the primary genetic defect has yet to be
identified in all but one of these models. Therefore, these animals
have been useful in the analysis of the potential secondary events
in cyst formation. The results from these experiments suggest that
cells lining the cysts exhibit an immature phenotype, express
elevated levels of several protooncogenes and have abnormalities
in cellular polarity. Specifically, the EGFr was mislocalized to the
apical surface of the cystic collecting duct epithelium in several of
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the animal models as well as in human patients with ARPKD
[12—15]. While these studies have contributed significantly to the
understanding of renal cystic disease, they have not necessarily
provided information on the initiating events that lead to cyst
formation. Therefore, it is critical that genes directly involved in
the etiology of renal cystic disease be identified and characterized.
In this regard, we previously described an insertional mutation
in the mouse TgN737Rpw that develops a form of PKD with a
renal pathology that is similar to human ARPKD [16, 171. The
unique feature of the TgN737Rpw model over other models is
that we have cloned and characterized a candidate gene (Tg737)
from the mutant locus and have determined that expression of this
gene is altered in the mutant animals. Here we describe the
correction of renal function and rescue of the collecting duct
lesion in mutant animals by expressing the full-length Tg737
eDNA as a transgene under the control of the human beta-actin
promoter. This result confirms a direct role for Tg737 in renal
cystic disease.
Methods
Construction of the rescue transgene and generation of transgenic
animals
The full length Tg737 cDNAS was excised from pGem4 as an
EcoRI fragment [171. The EcoRI ends were filled with Kienow
and a HindIII site added by linker ligation [181 and then cloned
into the HindIlI site of pBAP.2 [19]. The rescue transgene was gel
purified away from the vector sequence after ClaI restriction
enzyme digestion. The transgene (3 ng/pi in 10 mivi Tris pH 7.5/0.1
mM EDTA) was microinjected into one-cell FVB/N embryos and
transgenic animals were derived as described [20]. All mice were
maintained at the Oak Ridge National Laboratory.
DNA and RNA analysis
Kidney, liver and muscle RNA and tail biopsy DNA were
isolated as described [21]. Southern and Northern blot analyses
were performed as described [18]. RNAse protection analysis was
performed according to the RPA II kit (Ambion, Austin, TX,
USA) using 10 jxg of total RNA and the 400 basepair probe shown
in Figure 1A. The -actin fragment included with RPA II kit was
used as an internal control.
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Fig. 1. (A) Structure of the rescue transgene. A
full length Tg737 cDNA was cloned into an
expression cassette containing the human J3-
actin promoter and the first untranslated exon I
(UTR), intron (IVS) and splice acceptor site
(black box) [19, 311. The SV4O polyadenylation
signal was cloned 3' to Tg737 cDNA. The
translation initiation site (ATG) is located in
the Tg737 cDNA. The location of probes used
for RNAse protection analysis (hatched box)
and genotyping for the rescue transgene are
indicated (solid box). (B) Genotyping individual
animals for the TgN737Rpw insertional
mutation and rescue transgene. Genomic DNA
was digested with EcoRI and BamHI and
hybridized with the probe indicated in IA (solid
box, rescue transgene) and as described
previously [17]. The mutant locus appears as a
4.2 kb EcoRI band while the corresponding
wild-type allele is a 3.0 kb band. The rescue
transgene probe hybridizes to a 1.0 kb BamHI
fragment of the endogenous TgN737Rpw locus
and to a 0.7 kh fragment specific for the rescue
transgene. Animal numbers are indicated above
the autoradiograph. (C) RNAse protection
analysis of the Tg737 rescue transgene.
Expression of the rescue transgenes was
analyzed using 10 rg of total RNA isolated
from kidney, liver and muscle of TgN737Rpw
mutant and rescue animals using the probe
shown in IA (hatched box).
Histolo8y analysis
Kidneys were isolated from mutant, wild-type and rescue
animals at the ages indicated and fixed in 4% buffered formalin
for 12 hours and then processed with paraffin wax embedding
using standard techniques [22]. Sections (5 to 8 M) were cut and
attached to Probe-On Plus slides (Fisher Scientific, Pittsburgh,
PA, USA). Slides were dewaxed and counter-stained with hema-
toxylin and eosin.
DBA and LTA staining of histological sections and determination
of the cystic index
Cyst localization was studied by segment-specific lectin binding
using Dolichos biflorus (DBA) as a marker specific for collecting
tubules (CT) and Lotus tetragonolobus (LTA) as a marker specific
for proximal tubules (PT) [23, 24]. Processing and immunostain-
ing of tissues was performed as previously described using a
post-embedding technique specifically developed for immunolo-
calization of antigens and lectins in plastic sections [25]. The
degree of collecting and proximal tubular cyst formation was
quantitated using a cystic index [26, 27], derived from basic light
morphometric methods and standardized as a tool for analyzing
cyst formation in organ culture systems [281. Following routine
histological preparation, 6 to 10 regularly spaced, 3 sections of
kidneys were graded for cyst formation using an eyepiece micro-
meter on a scale of 0 (no observable cysts) through 4 (multiple
cysts larger than 0.2 mM). The cystic index was then calculated as
the mean of individual cyst scores.
Analysis of renal function
Serum from retro-orbital sinus puncture and urine was isolated
from adult mice (21 days or older) at random times from mutant,
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sured using a pressure osmometer (Wescor, Logan, UT, USA).
Urine specific gravity was determined using refractometry.
Immunohistological localization of the EGFr
The cellular localization of the EGFr was determined by
immunohistological staining of mutant, rescue and wild-type
kidney sections with monoclonal EGFr antibodies, F-4 (Sigma, St.
Louis, MO, USA) or HB 8506 (American Type Tissue Collection,
Rockville, MD, USA) or the rabbit antiserum, RK-2 as described
(13, 25, 29].
Results
Fig. 2. Variability in the gross appearance of the rescue animals. (A) On one
extreme, the rescued animals (left) were intermediate in size compared
with the mutant (middle) and wild-type (right) littermates, and did not
exhibit the scruffy fur characteristic of the mutants. (B) On the other
extreme, rescue animals (animals on the left and right) were visually
indistinguishable from a wild-type littern1ate (middle).
wild-type and rescue animals. Serum enzyme concentrations were
measured using an automated biochemical analyzer (Abbot Spec-
trum, Irving, TX, USA). Urine and serum osmolality was mea-
The Tg737 gene is directly associated with the mutant locus in
the TgN737Rpw mutant mouse and encodes a prominent 3.2 kb
mRNA that is expressed in all of the tissues that we have
examined from a normal adult animal [171. In addition, expression
of two low abundance transcripts of about 5 and 7 kb are also
detectable. The level of the 3.2 kb transcript expression is variable
between tissues, with highest levels being detected in the kidney
and brain and the lowest in the liver (Moyer et al, unpublished
data). Previously we described the cloning of a full-length 3 kb
eDNA that contains the entire coding region of the Tg737 3.2 kb
mRNA. Based on our sequencing of the eDNA, we determined
that the Tg737 gene has the potential to encode an 826 amino acid
protein which contains 10 copies of a motif referred to as the
tetratricopeptide repeat (TPR) [30].
To unequivocally demonstrate that disruption of the Tg737
gene is directly responsible for the mutant phenotype, we sought
to rescue the mutant traits by expressing the cloned wild-type
Tg737 eDNA as a transgene in mutant animals. The rescue
transgene contains the 3 kb Tg737 eDNA, called cDNA5, ex-
pressed from the human /3-actin promoter (Fig. 1A) [19, 311. The
/3-actin promoter was chosen for these experiments in an attempt
to recapitulate the broad tissue expression pattern observed with
the normal Tg737 gene (Moyer et al, unpublished data).
Eight lines of transgenic mice were generated with the rescue
expression cassette. Transgenic carrier mice from each line were
crossed with animals heterozygous for the TgN737Rpw mutation
to generate individual animals that were both heterozygous for
the TgN737Rpw mutation and also contained the rescue trans-
gene. These animals were inter-crossed to produce progeny that
were homozygous for the TgN737Rpw mutation and also con-
tained the rescue transgene. Each of the individual animals was
analyzed by Southern blot analysis to establish their genotype
(Fig. IB). Expression of the Tg737 eDNA from the rescue
transgene was analyzed with total RNA isolated from kidney, liver
and muscle using an RNAse protection assay (Fig. IC) and by
RT-PCR (data not shown). Of the eight transgenic lines gener-
ated, only one (TgN48l3Rpw) expressed the transgene at detect-
able levels in the kidney and liver, although the level of expression
was determined to be much less than that from the wild-type
Tg737 gene (data not shown). No abnormalities were detected in
wild-type animals which were either heterozygous or homozygous
for the rescue transgene in the TgN48i3Rpw line. All subsequent
analyses were performed with the rescue transgene in the
TgN48l3Rpw line.
Improved growth, survival and renal function in rescued mice
Further analysis of the animals that were TgN737Rpw mutant
homozygotes and expressed the rescue trarisgene, hereafter re-
ferred to as "rescued" animals, displayed some variability in their
total body size. On the one extreme, rescued animals were visually
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Fig. 3. Analysis of (A) urine specific gravily and
(B) urine:serum osmolality ratio in wild-type
mutant rescue animals.
Fig. 4. Histological analysis of the kidney from mutant and rescue animals. Sections of mutant and rescue kidneys were stained with Dolichos bifiorus
(DBA, dark red) and Lotus tetragonolobus (LTA, brown) or counter-stained with eosin and hematoxylin. Comparison of the kidney morphology from
a (A) 28-day-old rescue (animal 173) and (B) mutant (animal 175) mouse. (C) DBA staining of a section from a 54-day-old mutant kidney shows the
typical collecting tubule cysts and resulting damage to surrounding parenchyma (D). LTA and DBA staining of kidney section from a 68-day-old rescue
animal. (E) DBA and LTA histological localization of cysts in a 141-day-old rescue animal. In contrast to what is observed in mutant animals at this
age, rescue animals exhibit much fewer collecting tubule cysts, however, several proximal tubule cysts arc evident (arrow).
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indistinguishable from their wild-type littermates, while others
exhibited a degree of runting that was intermediate between the
TgN737Rpw mutants and wild-type animals (Fig. 2). The degree
to which the growth retardation was corrected was independent of
whether animals were homozygous or heterozygous for the rescue
transgene. The majority of the rescued animals survived past
weaning (21 days) with several living for as long as 10 months to
a year of age (data not shown). This is in contrast to the mutant
animals that usually do not survive past two weeks after birth, and
where only an occasional mutant survives past 30 days of age (data
not shown).
To assay the effect of expression of the rescue transgene on
renal tubular function, we evaluated the ability of the rescue
animals to concentrate urine (Fig. 3). Inability to concentrate
urine is commonly observed as an early manifestation of renal
structural abnormalities in patients with ARPKD [32, 33]. Urine
specific gravity was evaluated at random time points from wild-
type, mutant and rescued adult (21 days or older) mice main-
tained on identical diets. To further assay concentrating ability
and to control for different states of hydration of the mice at the
time of sample collection, we also determined the urine/serum
osmolality ratio (U0,,:S0). The results demonstrate that the
rescue animals are able to concentrate urine nearly as efficiently as
their wild-type controls with specific gravities of 1.047 0.009 (±
so) versus 1.049 0.012 and Uosm:So values of 5.84 1.23
versus 6.26 0.98, respectively (Fig. 3). In contrast, the mutant
animals showed a marked reduction in their ability to concentrate
urine with specific gravities and U0:S0 values of 1.019
0.003 and 1.92 0.39, respectively (P < 0.005).
Since creatinine and blood urea nitrogen levels (BUN) levels
are elevated in patients in later stages of ARPKD, we also
evaluated these parameters in our mice [33-35]. Neither the
rescue or mutant animals had elevated BUN or creatinine levels
(data not shown), which likely reflects an early stage renal lesion
in this model [17].
Histological analysis of the rescued kidneys
Fig. 5. Localization of renal cysts and cystic index in kidneys from wild-type,
mutant and rescue animals. Sections of kidneys were stained with (A) LTA
and (B) DBA to identify proximal and collecting tubules, respectively. The
percentage of either LTA or DBA positive tubules which were cystic was
determined for rescue (•), mutant () and wild-type (A) animals. (C)
Cystic index of rescue and mutant animals. Sections of kidney were graded
for cyst formation in DBA or LTA positive tubular segments on a scale of
0 (no obvious cysts) through 4 (multiple cysts larger than 0.2 mM). The
cystic index for each animal was calculated as the mean of the individual
cyst scores. Data arc presented as an average of all animals < 30 days or>
30 days of age. No cysts were detected in wild-type controls.
Renal morphology was analyzed by comparing histological
sections of tissue samples from mutant and rescue animals (Fig. 4
A through E). The age of the animals that were analyzed ranged
from 13 days to five months of age. Nephron segments within the
kidney were identified by lectin profile analysis using lectins
Dolichos bifiorus (DBA) and Lotus tetragonolobus (LTA), which
identify collecting (CT) and proximal tubules (PT), respectively.
Data are presented as the percentage of total proximal or
collecting tubules within a field which were cystic (Fig. 5 A, B).
Kidneys from young rescued animals (less than 30 days old)
were essentially morphologically normal (Fig. 4A). At this stage
TgN737Rpw mutant kidneys contain cysts in as many as 14.6% of
their proximal tubules and 14.2% collecting tubules (average
number of PT and CT cysts was 6% and 8%, respectively; N = 6).
In contrast, all three of the rescued animals under 30 days of age
were completely free of CT cysts (Figs. 4A and 5B). Furthermore,
two of the three rescued animals (< 30 days of age) analyzed had
no PT cysts, while the third rescue animal contained a small
number of PT cysts (2.6%). The vast improvement in the kidney
phenotype was also evident in the CT of older rescue animals (31
days and older; Figs. 4 C, D, E and 5B). At this stage, mutant
kidneys on average contained cysts in 39% of the CT (N = 5). In
contrast, only 3.2% of the CT were found to be cystic in rescue
animals with 3 of the 8 animals having no CT cysts. Interestingly,
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the percentage of PT cysts was found to increase in the older
rescue animals compared to mutants. However, the size of the PT
cysts in the rescued mice was much smaller than those in
age-matched mutants. The PT cysts detected in the oldest rescue
animal analyzed (Fig. 4E) caused little damage to surrounding
parenchyma and appeared not to affect renal function.
To further quantitate the difference between the rescue and
mutant renal lesions, we determined the cystic index (CI), which
measures both the number and the size of cystic structures (Fig.
5C) [26]. This analysis confirmed the finding that the early stage
rescued kidneys are essentially normal with an average CI value of
0.33 compared with an average CI of 2.0 for mutant animals.
Additionally, this analysis confirmed that although the rescue
animals contain numerous PT cysts at late stages, the volume of
these cysts is significantly reduced compared to cysts in mutants
with CI average values of 1.3 for rescue animals and 3.2 for the
mutants.
Analysis of EGFr targeting in collecting duct epithelium of wild-
type, mutant and rescue animals
Tubular and ductual hyperplasia is a salient feature of the renal
defect in human ARPKD. Recent studies have focused on the role
of TGF-a and EGF along with their common receptor (EGFr) in
the epithelial hyperplasia. Results from these studies indicate that
in human ARPKD and in mice carrying the cpk mutation, the
EGFr was mislocalized from the basolateral to both basolateral
and apical surfaces of cystic collecting duct epithelium [36—38]. To
determine whether this was a feature of the mutant trait in the
TgN737Rpw line, we analyzed the location of the EGFr in kidney
sections from adult mutant and wild-type animals by immunocy-
tochemistry (Fig. 6 A, B). As with human ARPKD, the EGFr was
found to be mislocalized to both basolateral and apical surfaces of
the cystic collecting duct epithelium. In contrast, the EGFr was
localized to the normal basolateral surface of all proximal tubules
cysts (data not shown).
Since expression of the rescue transgene was able to correct
renal function, we also evaluated whether mislocalization of the
EGFr was corrected in the rescue animals (Fig. 6C). The EGFr
was localized properly on the basolateral surfaces of all the
non-cystic CT epithelium in the rescue mice. Spotty apical expres-
sion of the EGFr on some of the CT cysts was observed, however,
in older rescue animals (Fig. 6C).
Discussion
We previously described a new mutation in the mouse, named
TgN737Rpw, which has renal defects that closely resemble human
ARPKD [16, 17]. As observed in human ARPKD, the initial
lesions detected in these mutant mice are dilations of the proximal
tubules. At later stages in the disease, the primary renal defect is
characterized by formation of massive collecting duct cysts that
lead to renal insufficiency.
Since the TgN737Rpw mutant was generated by insertional
mutagenesis, we were able to use sequences flanking the trans-
gene insertion site to clone a candidate gene (Tg737) whose
expression is altered in mutant animals. Here we demonstrate that
expression of a wild-type Tg737 eDNA, as a transgene in the
mutant animals, has the ability to rescue renal function and the
collecting tubule cysts. The correction of the renal trait was
especially apparent in young rescue mice when the majority of the
mutant animals would normally succumb to the disease. In the
older rescue animals that survive past weaning age, a few collect-
ing tubule cysts were detected; however, the cystic index revealed
that the size and parenchyma damage caused by these lesions was
not nearly as severe as those in the mutants. Additionally, the
kidneys in these rescue mice retained their functional ability to
concentrate urine. These data provide evidence that the Tg737
gene is directly associated with the kidney phenotype in
TgN737Rpw mutants.
It is noteworthy that the older rescued animals developed more
proximal tubule cysts than age-matched mutants. It is possible
that the increase in proximal tubule cysts is not detected in older
mutant animals because of renal damage due to the expansion of
the collecting tubule cysts. Overall, the renal histopathology in the
rescue animals resembles the early stages of the disease, which
suggests that expression from the rescue transgene blocks the
progression of the disease beyond the formation of the early
proximal tubule lesions.
The reason for the differential rescue of the collecting tubule
and proximal tubule traits is not clear. It is possible that the
/3-actin promoter fails to recapitulate the normal temporal or
spatial pattern of expression necessary to elicit correction of the
proximal tubule lesion. Additionally, the overall level of Tg737
expression from the rescue transgene was very low and may not be
adequate to correct this defect. Alternatively, there could be an
additional spliced version of the Tg737 mRNA that is functional in
the proximal tubules that is distinct from the eDNA used in these
experiments. The latter issue is a possibility since higher molecu-
lar weight forms of mRNA are detected in most tissues where the
gene is expressed [17]. Another possibility is that there is another
gene in the region of the mutant locus, perhaps within one of the
introns of the Tg737 gene and/or on the other strand in the
opposite transcriptional orientation, whose expression is also
affected by the mutation. To address at least some of these issues,
we are currently generating rescue animals that contain the Tg737
eDNA expressed from its own promoter as well as generating an
additional allele of TgN737Rpw by homologous recombination to
perform a complementation experiment.
The human f3-actin promoter that was used in these experi-
ments has been used for the production transgenies with other
cDNAs in our laboratory (Michaud, unpublished results) [31]. In
all cases, the transgene was expressed nearly ubiquitously at high
levels. Therefore, our finding that only one of the eight transgenic
lines generated with the /3-actin Tg737 eDNA expressed the
transgene, and in this case expressed the transgene at a very low
level, suggests that high level eetopic expression of the Tg737
protein may be deleterious to the embryo and cause developmen-
tal arrest. This possibility is compatible with our finding that the
Tg737 protein contains ten copies of the TPR motif, which is likely
to be involved in protein-protein interaction [30, 39, 40]. The TPR
motif has been identified in several proteins involved in regulation
of cell cycle [30, 41]. Perhaps by ectopically expressing the Tg737
protein at high levels in the embryo we are causing a dominant
effect resulting in disruption of cell cycle regulation.
Hyperplasia is a salient feature of many human and murine
renal cystic disorders as well as in the TgN737Rpw mutants
[42-44]. Recent studies have implicated a role for EGFr and its
ligands, EGF and TGF-, in cystic tubular epithelial hyperplasia
[13, 14, 37, 45]. Increased expression and mislocalization of the
EGFr along with high levels of biologically active EGF-like
peptides in cyst fluid have been reported in human PKD as well as
in the cpk mouse model for PKD. Here we also demonstrate the
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Fig. 6. Immunohistochemical localization of the
EGFr in the collecting tubules of (A) mutant (B)
wild-type and (C) rescue animals. In the non-
cystic tubules in both wild-type, rescue and
mutant samples, the EGFr is localized strictly
on the basolateral surface. In contrast, in cystic
epithelium, the EGFr is localized to both the
apical and hasolateral surfaces. In rescue
kidneys, the EGFr was detected predominately
on the hasolateral surface of collecting duct
epithelium, with occasional spotty apical
presentation on CT cysts in the older rescues
(arrow).
mislocalization of the EGFr to the apical surface of cystic the older animals. Interestingly, the EGFr is localized correctly to
collecting ducts in TgN737Rpw mutants. In contrast, the rescue the basolateral surface of all proximal tubule cysts in both mutant
animals have normal hasolateral localization of EGFr on collect- and rescue animals. This result suggests that there are intrinsic
ing tubule epithelium, with an exception in a few cysts detected in differences between the formation or maintenance of cysts in the
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collecting tubules and proximal tubules. Since EGF is primarily
synthesized and secreted into the lumen at the distal end of the
nephron, the collecting duct epithelium with apical as well as
basolateral EGFr may be more responsive to EGF than proximal
tubule cells. The differential correction of the renal lesions in the
rescue animals will allow a more detailed analysis of the early
stages of renal cystic disorders and of the role of EGFr mislocal-
ization in cyst formation and maintenance.
Since expression of Tg737 in the rescue animals is able to
correct the mislocalization of the EGFr, it is possible that Tg737
protein may function in regulating trafficking of the EGFr.
However, this does not explain the normal localization seen in
proximal tubules or in non-cystic epithelium. Alternatively, the
mislocalization of the EGFr could be a secondary consequence of
cyst expansion and not a primary causative event, particularly
since it is common to several forms of human and murine PKD.
The fact that mislocalization of the EGFr is common to several
different renal cystic diseases raises the possibility that therapeutic
intervention may be accomplished by inhibition of the EGFr
tyrosine kinase activity.
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